{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T07:41:50Z","timestamp":1760686910237,"version":"build-2065373602"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T00:00:00Z","timestamp":1760659200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Folia Microbiol"],"DOI":"10.1007\/s12223-025-01352-7","type":"journal-article","created":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T05:48:32Z","timestamp":1760680112000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of ompK35 and ompK36 downregulation on antibiotic resistance in clinical carbapenem-resistant Klebsiella pneumoniae isolates"],"prefix":"10.1007","author":[{"given":"Davood","family":"Kalantar-Neyestanaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sajad","family":"Aslani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saba","family":"Karimitabar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seyed Moein","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Ziasistani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9793-0092","authenticated-orcid":false,"given":"Sanaz","family":"Rastegar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahsa","family":"Kiaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,17]]},"reference":[{"key":"1352_CR1","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.4314\/jopat.v23i2.6","volume":"23","author":"OT Akinola","year":"2024","unstructured":"Akinola OT, Dahunsi SO, Okoh A (2024) Detection of OMPKs 36\/37 porins and other resistance determinants in extended spectrum beta-lactamases (ESBLs)-producing K. pneumoniae. Journal of Phytomedicine and Therapeutics 23:1461\u20131471","journal-title":"J Phytomedicine Ther"},{"key":"1352_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2024.1367422","volume":"15","author":"L Assoni","year":"2024","unstructured":"Assoni L, Couto AJM, Vieira B et al (2024) Animal models of Klebsiella pneumoniae mucosal infections. Front Microbiol 15:1367422","journal-title":"Front Microbiol"},{"key":"1352_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/antibiotics11030421","volume":"11","author":"C Aurilio","year":"2022","unstructured":"Aurilio C, Sansone P, Barbarisi M et al (2022) Mechanisms of action of carbapenem resistance. Antibiotics 11:421","journal-title":"Antibiotics"},{"key":"1352_CR4","doi-asserted-by":"publisher","first-page":"2407","DOI":"10.1007\/s10096-024-04958-w","volume":"43","author":"M Boattini","year":"2024","unstructured":"Boattini M, Bianco G, Comini S et al (2024) In vivo development of resistance to novel \u03b2-lactam\/\u03b2-lactamase inhibitor combinations in KPC-producing Klebsiella pneumoniae infections: a case series. Eur J Clin Microbiol Infect Dis 43:2407\u20132417","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1352_CR5","doi-asserted-by":"publisher","first-page":"5215","DOI":"10.1038\/s41598-024-55705-2","volume":"14","author":"N Chirabhundhu","year":"2024","unstructured":"Chirabhundhu N, Luk-In S, Phuadraksa T et al (2024) Occurrence and mechanisms of tigecycline resistance in carbapenem-and colistin-resistant Klebsiella pneumoniae in Thailand. Sci Rep 14:5215","journal-title":"Sci Rep"},{"key":"1352_CR6","unstructured":"CLSI (2024) Performance standards for antimicrobial susceptibility testing. 34th ed. CLSI. Supplment M100. Clinical and Laboratory Standards Institute"},{"key":"1352_CR7","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0222628","volume":"14","author":"M Cubero","year":"2019","unstructured":"Cubero M, Marti S, Dom\u00ednguez M\u00c1 et al (2019) Hypervirulent Klebsiella pneumoniae serotype K1 clinical isolates form robust biofilms at the air-liquid interface. PLoS ONE 14:e0222628","journal-title":"PLoS ONE"},{"key":"1352_CR8","doi-asserted-by":"crossref","unstructured":"Delcour AH (2009) Outer membrane permeability and antibiotic resistance. Biochim Biophys Acta (BBA)-Proteins Proteomics 1794:808\u2013816","DOI":"10.1016\/j.bbapap.2008.11.005"},{"key":"1352_CR9","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.561741","volume":"10","author":"EG Di Domenico","year":"2020","unstructured":"Di Domenico EG, Cavallo I, Sivori F et al (2020) Biofilm production by carbapenem-resistant Klebsiella pneumoniae significantly increases the risk of death in oncological patients. Front Cell Infect Microbiol 10:561741","journal-title":"Front Cell Infect Microbiol"},{"key":"1352_CR10","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1080\/14787210.2024.2305854","volume":"22","author":"V Di Pilato","year":"2024","unstructured":"Di Pilato V, Pollini S, Miriagou V et al (2024) Carbapenem-resistant Klebsiella pneumoniae: the role of plasmids in emergence, dissemination, and evolution of a major clinical challenge. Expert Rev Anti-infect Ther 22:25\u201343","journal-title":"Expert Rev Anti-infect Ther"},{"key":"1352_CR11","doi-asserted-by":"crossref","unstructured":"El-Kady RAE-H, Elbaiomy MA, Elnagar RM (2022) Molecular mechanisms mediating ceftazidime\/avibactam resistance amongst carbapenem-resistant Klebsiella pneumoniae isolates from cancer patients. Infect Drug Resist 5929\u20135940","DOI":"10.2147\/IDR.S384972"},{"key":"1352_CR12","doi-asserted-by":"publisher","DOI":"10.1186\/s12866-024-03600-1","volume":"24","author":"AT El-Kholy","year":"2024","unstructured":"El-Kholy AT, El-Kholy MA, Omar H, Aboulmagd E (2024) Co-existence of antibiotic resistance and virulence factors in carbapenem resistant Klebsiella pneumoniae clinical isolates from Alexandria, Egypt. BMC Microbiol 24:466","journal-title":"BMC Microbiol"},{"key":"1352_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2021.104743","volume":"152","author":"R Fang","year":"2021","unstructured":"Fang R, Liu H, Zhang X et al (2021) Difference in biofilm formation between carbapenem-resistant and carbapenem-sensitive Klebsiella pneumoniae based on analysis of mrkH distribution. Microb Pathog 152:104743","journal-title":"Microb Pathog"},{"key":"1352_CR14","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1111\/j.1469-0691.2011.03515.x","volume":"18","author":"J Findlay","year":"2012","unstructured":"Findlay J, Hamouda A, Dancer SJ, Amyes SGB (2012) Rapid acquisition of decreased carbapenem susceptibility in a strain of Klebsiella pneumoniae arising during meropenem therapy. Clin Microbiol Infect 18:140\u2013146","journal-title":"Clin Microbiol Infect"},{"key":"1352_CR15","doi-asserted-by":"publisher","first-page":"4742","DOI":"10.1128\/AAC.00309-11","volume":"55","author":"L Garc\u00eda-Sureda","year":"2011","unstructured":"Garc\u00eda-Sureda L, Dom\u00e9nech-S\u00e1nchez A, Barbier M et al (2011a) OmpK26, a novel porin associated with carbapenem resistance in Klebsiella pneumoniae. Antimicrob Agents Chemother 55:4742\u20134747","journal-title":"Antimicrob Agents Chemother"},{"key":"1352_CR16","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1128\/AAC.01441-10","volume":"55","author":"L Garc\u00eda-Sureda","year":"2011","unstructured":"Garc\u00eda-Sureda L, Juan C, Dom\u00e9nech-S\u00e1nchez A, Albert\u00ed S (2011b) Role of Klebsiella pneumoniae LamB porin in antimicrobial resistance. Antimicrob Agents Chemother 55:1803\u20131805","journal-title":"Antimicrob Agents Chemother"},{"key":"1352_CR17","doi-asserted-by":"publisher","first-page":"898","DOI":"10.1016\/j.ijantimicag.2018.03.020","volume":"52","author":"Z Hamzaoui","year":"2018","unstructured":"Hamzaoui Z, Ocampo-Sosa A, Martinez MF et al (2018) Role of association of OmpK35 and OmpK36 alteration and blaESBL and\/or blaAmpC genes in conferring carbapenem resistance among non-carbapenemase-producing Klebsiella pneumoniae. Int J Antimicrob Agents 52:898\u2013905","journal-title":"Int J Antimicrob Agents"},{"key":"1352_CR18","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S227955","author":"Z Hashemizadeh","year":"2020","unstructured":"Hashemizadeh Z, Hosseinzadeh Z, Azimzadeh N, Motamedifar M (2020) Dissemination pattern of multidrug resistant carbapenemase producing Klebsiella pneumoniae isolates using pulsed-field gel electrophoresis in southwestern Iran. Infect Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S227955","journal-title":"Infect Drug Resist"},{"key":"1352_CR20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106342","volume":"57","author":"P-H Huang","year":"2021","unstructured":"Huang P-H, Cheng Y-H, Chen W-Y (2021) Risk factors and mechanisms of in vivo emergence of colistin resistance in carbapenem-resistant Klebsiella pneumoniae. Int J Antimicrob Agents 57:106342","journal-title":"Int J Antimicrob Agents"},{"key":"1352_CR21","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.00381-22","volume":"10","author":"P-H Huang","year":"2022","unstructured":"Huang P-H, Chen W-Y, Chou S-H et al (2022) Risk factors for the development of colistin resistance during colistin treatment of carbapenem-resistant Klebsiella pneumoniae infections. Microbiol Spectr 10:e00381\u201322","journal-title":"Microbiol Spectr"},{"key":"1352_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jiph.2024.102544","volume":"17","author":"RA Hussein","year":"2024","unstructured":"Hussein RA, Al-Kubaisy SH, Al-Ouqaili MTS (2024) The influence of efflux pump, outer membrane permeability and \u03b2-lactamase production on the resistance profile of multi, extensively and pandrug resistant Klebsiella pneumoniae. J Infect Public Health 17:102544","journal-title":"J Infect Public Health"},{"key":"1352_CR23","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s43088-024-00470-4","volume":"13","author":"TXN Huy","year":"2024","unstructured":"Huy TXN (2024) Overcoming Klebsiella pneumoniae antibiotic resistance: new insights into mechanisms and drug discovery. Beni-Suef Univ J Basic Appl Sci 13:13","journal-title":"Beni-Suef Univ J Basic Appl Sci"},{"key":"1352_CR24","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2022.823684","volume":"12","author":"S-S Jean","year":"2022","unstructured":"Jean S-S, Harnod D, Hsueh P-R (2022) Global threat of carbapenem-resistant gram-negative bacteria. Front Cell Infect Microbiol 12:823684","journal-title":"Front Cell Infect Microbiol"},{"key":"1352_CR25","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1128\/AAC.00285-06","volume":"50","author":"FM Kaczmarek","year":"2006","unstructured":"Kaczmarek FM, Dib-Hajj F, Shang W, Gootz TD (2006) High-level carbapenem resistance in a Klebsiella pneumoniae clinical isolate is due to the combination of bla ACT-1 \u03b2-lactamase production, porin OmpK35\/36 insertional inactivation, and down-regulation of the phosphate transport porin PhoE. Antimicrob Agents Chemother 50:3396\u20133406","journal-title":"Antimicrob Agents Chemother"},{"key":"1352_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.2217\/fmb-2016-0042","volume":"11","author":"T Karampatakis","year":"2016","unstructured":"Karampatakis T, Antachopoulos C, Iosifidis E et al (2016) Molecular epidemiology of carbapenem-resistant Klebsiella pneumoniae in Greece. Future Microbiol 11:809\u2013823","journal-title":"Future Microbiol"},{"key":"1352_CR27","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1099\/jmm.0.012575-0","volume":"58","author":"D Landman","year":"2009","unstructured":"Landman D, Bratu S, Quale J (2009) Contribution of OmpK36 to carbapenem susceptibility in KPC-producing Klebsiella pneumoniae. J Med Microbiol 58:1303\u20131308","journal-title":"J Med Microbiol"},{"key":"1352_CR28","doi-asserted-by":"publisher","DOI":"10.3201\/eid2910.230153","volume":"29","author":"J Lee","year":"2023","unstructured":"Lee J, Sunny S, Nazarian E et al (2023) Carbapenem-resistant Klebsiella pneumoniae in large public acute-care healthcare system, New York, New York, USA, 2016\u20132022. Emerg Infect Dis 29:1973","journal-title":"Emerg Infect Dis"},{"key":"1352_CR29","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2024.1464816","volume":"14","author":"YQ Lee","year":"2024","unstructured":"Lee YQ, Sri La Sri Ponnampalavanar S, Wong JH et al (2024) Investigation on the mechanisms of carbapenem resistance among the non-carbapenemase-producing carbapenem-resistant Klebsiella pneumoniae. Front Cell Infect Microbiol 14:1464816","journal-title":"Front Cell Infect Microbiol"},{"key":"1352_CR30","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.jgar.2021.04.006","volume":"25","author":"B Leng","year":"2021","unstructured":"Leng B, Yan G, Wang C et al (2021) Dose optimisation based on pharmacokinetic\/pharmacodynamic target of tigecycline. J Glob Antimicrob Resist 25:315\u2013322","journal-title":"J Glob Antimicrob Resist"},{"key":"1352_CR31","unstructured":"Li N, Chen H, Li Y et al (2024a) Related factors of CRKP infection in neurosurgery and comparison of therapeutic effects of tigecycline versus polymyxin B for CRKP infection. Altern Ther Heal Med 30:112-116"},{"key":"1352_CR32","doi-asserted-by":"publisher","DOI":"10.2147\/IDR.S453025","author":"Y Li","year":"2024","unstructured":"Li Y, Kumar S, Zhang L (2024b) Mechanisms of antibiotic resistance and developments in therapeutic strategies to combat Klebsiella pneumoniae infection. Infect Drug Resist. https:\/\/doi.org\/10.2147\/IDR.S453025","journal-title":"Infect Drug Resist"},{"key":"1352_CR33","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0285730","volume":"18","author":"M Liu","year":"2023","unstructured":"Liu M, Zheng L, Zhu L et al (2023) Characteristics of carbapenem-resistant Klebsiella pneumoniae in sewage from a tertiary hospital in Jilin Province, China. PLoS ONE 18:e0285730","journal-title":"PLoS ONE"},{"key":"1352_CR34","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2023.1325077","volume":"14","author":"G Mendes","year":"2023","unstructured":"Mendes G, Santos ML, Ramalho JF et al (2023) Virulence factors in carbapenem-resistant hypervirulent Klebsiella pneumoniae. Front Microbiol 14:1325077","journal-title":"Front Microbiol"},{"key":"1352_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.microb.2025.100246","author":"D Mohammadpour","year":"2025","unstructured":"Mohammadpour D, Memar MY, Leylabadlo HE et al (2025) Carbapenem-resistant Klebsiella pneumoniae: a comprehensive review of phenotypic and genotypic methods for detection. The Microbe. https:\/\/doi.org\/10.1016\/j.microb.2025.100246","journal-title":"The Microbe"},{"key":"1352_CR36","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0139116","volume":"10","author":"T Netikul","year":"2015","unstructured":"Netikul T, Kiratisin P (2015) Genetic characterization of carbapenem-resistant Enterobacteriaceae and the spread of carbapenem-resistant Klebsiella pneumonia ST340 at a university hospital in Thailand. PLoS ONE 10:e0139116","journal-title":"PLoS ONE"},{"key":"1352_CR37","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.3389\/fmicb.2018.01422","volume":"9","author":"M-H Nicolas-Chanoine","year":"2018","unstructured":"Nicolas-Chanoine M-H, Mayer N, Guyot K et al (2018) Interplay between membrane permeability and enzymatic barrier leads to antibiotic-dependent resistance in Klebsiella pneumoniae. Front Microbiol 9:1422","journal-title":"Front Microbiol"},{"key":"1352_CR38","doi-asserted-by":"publisher","first-page":"26","DOI":"10.7326\/0003-4819-140-1-200401060-00008","volume":"140","author":"DL Paterson","year":"2004","unstructured":"Paterson DL, Ko W-C, Gottberg AV et al (2004) International prospective study of Klebsiella pneumoniae bacteremia: implications of extended-spectrum \u03b2-lactamase production in nosocomial infections. Ann Intern Med 140:26\u201332","journal-title":"Ann Intern Med"},{"key":"1352_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1089\/mdr.2016.0017","volume":"23","author":"L Pulzova","year":"2017","unstructured":"Pulzova L, Navratilova L, Comor L (2017) Alterations in outer membrane permeability favor drug-resistant phenotype of Klebsiella pneumoniae. Microb Drug Resist 23:413\u2013420","journal-title":"Microb Drug Resist"},{"key":"1352_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2019.103924","volume":"139","author":"W Qian","year":"2020","unstructured":"Qian W, Sun Z, Wang T (2020) Antimicrobial activity of eugenol against carbapenem-resistant Klebsiella pneumoniae and its effect on biofilms. Microb Pathog 139:103924","journal-title":"Microb Pathog"},{"issue":"6","key":"1352_CR41","first-page":"745","volume":"29","author":"HA Rahdar","year":"2019","unstructured":"Rahdar HA, Malekabad ES, Dadashi AR et al (2019) Correlation between biofilm formation and carbapenem resistance among clinical isolates of Klebsiella pneumoniae. Ethiop J Health Sci 29(6):745\u2013750","journal-title":"Ethiop J Health Sci"},{"key":"1352_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-024-10081-0","volume":"24","author":"S Rastegar","year":"2024","unstructured":"Rastegar S, Skurnik M, Tadjrobehkar O et al (2024) Synergistic effects of bacteriophage cocktail and antibiotics combinations against extensively drug-resistant Acinetobacter baumannii. BMC Infect Dis 24:1\u201313","journal-title":"BMC Infect Dis"},{"key":"1352_CR43","doi-asserted-by":"publisher","first-page":"215","DOI":"10.2217\/fmb-2021-0211","volume":"18","author":"KS Rizi","year":"2023","unstructured":"Rizi KS, Aryan E, Youssefi M (2023) Characterization of carbapenem-resistant Escherichia coli and Klebsiella: a role for AmpC-producing isolates. Future Microbiol 18:215\u2013223","journal-title":"Future Microbiol"},{"key":"1352_CR44","doi-asserted-by":"publisher","first-page":"2317","DOI":"10.1007\/s00284-021-02479-9","volume":"78","author":"S Robatjazi","year":"2021","unstructured":"Robatjazi S, Nikkhahi F, Niazadeh M et al (2021) Phenotypic identification and genotypic characterization of plasmid-mediated AmpC \u03b2-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates in Iran. Curr Microbiol 78:2317\u20132323","journal-title":"Curr Microbiol"},{"key":"1352_CR45","doi-asserted-by":"publisher","DOI":"10.25122\/jml-2023-0139","volume":"16","author":"A Rusu","year":"2023","unstructured":"Rusu A, Tiliscan C, Adamescu A-I et al (2023) Carbapenemase-producing uropathogens in real life: epidemiology and treatment at a County Emergency Hospital from Eastern Romania. J Med Life 16:707","journal-title":"J Med Life"},{"key":"1352_CR46","first-page":"1","volume":"6","author":"P Shakib","year":"2012","unstructured":"Shakib P, Ghafourian S, Zolfaghary MR et al (2012) Prevalence of OmpK35 and OmpK36 porin expression in beta-lactamase and non-betalactamase-producing Klebsiella pneumoniae. Biologics 6:1\u20134","journal-title":"Biologics"},{"key":"1352_CR47","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1128\/AAC.01275-10","volume":"55","author":"Y-K Tsai","year":"2011","unstructured":"Tsai Y-K, Fung C-P, Lin J-C et al (2011) Klebsiella pneumoniae outer membrane porins OmpK35 and OmpK36 play roles in both antimicrobial resistance and virulence. Antimicrob Agents Chemother 55:1485\u20131493","journal-title":"Antimicrob Agents Chemother"},{"key":"1352_CR48","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1590\/S1517-83822013000200015","volume":"44","author":"W Shi","year":"2013","unstructured":"Shi W, Li K, Ji Y et al (2013) Carbapenem and cefoxitin resistance of Klebsiella pneumoniae strains associated with porin OmpK36 loss and DHA-1 \u03b2-lactamase production. Brazilian J Microbiol 44:435\u2013442","journal-title":"Brazilian J Microbiol"},{"key":"1352_CR49","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s15010-023-02094-9","volume":"52","author":"RA Sree","year":"2024","unstructured":"Sree RA, Gupta A, Gupta N et al (2024) Ceftazidime-avibactam alone or in combination with aztreonam versus polymyxins in the management of carbapenem-resistant Klebsiella pneumoniae nosocomial infections (CAPRI study): a retrospective cohort study from south India. Infection 52:429\u2013437","journal-title":"Infection"},{"key":"1352_CR50","doi-asserted-by":"publisher","first-page":"e00663","DOI":"10.1128\/aac.00663-24","volume":"68","author":"J Strahilevitz","year":"2024","unstructured":"Strahilevitz J, Motro Y, Temper V et al (2024) In vivo selection of carbapenem resistance during persistent Klebsiella pneumoniae sequence type 395 bloodstream infection due to OmpK36 deletion. Antimicrob Agents Chemother 68:e00663-e724","journal-title":"Antimicrob Agents Chemother"},{"key":"1352_CR51","first-page":"355","volume":"17","author":"A Taherpour","year":"2013","unstructured":"Taherpour A, Hashemi A (2013) Detection of OqxAB efflux pumps, OmpK35 and OmpK36 porins in extended-spectrum-\u03b2-lactamase-producing Klebsiella pneumoniae isolates from Iran. Hippokratia 17:355","journal-title":"Hippokratia"},{"key":"1352_CR52","doi-asserted-by":"crossref","unstructured":"Van Duijkeren E, Schink AK, Roberts M et al (2018) Mechanisms of bacterial resistance to antimicrobial agents. Microbiol Spectr 6(2):ARBA-0019","DOI":"10.1128\/microbiolspec.ARBA-0019-2017"},{"key":"1352_CR53","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1089\/mdr.2014.0226","volume":"21","author":"M Wassef","year":"2015","unstructured":"Wassef M, Abdelhaleim M, AbdulRahman E, Ghaith D (2015) The role of OmpK35, OmpK36 porins, and production of \u03b2-lactamases on imipenem susceptibility in Klebsiella pneumoniae clinical isolates, Cairo, Egypt. Microb Drug Resist 21:577\u2013580","journal-title":"Microb Drug Resist"},{"key":"1352_CR54","doi-asserted-by":"publisher","first-page":"5639","DOI":"10.2147\/IDR.S340652","volume":"14","author":"Y Xiong","year":"2021","unstructured":"Xiong Y, Han Y, Zhao Z et al (2021) Impact of carbapenem heteroresistance among multidrug-resistant ESBL\/AmpC-producing Klebsiella pneumoniae clinical isolates on antibiotic treatment in experimentally infected mice. Infect Drug Resist 14:5639\u20135650","journal-title":"Infect Drug Resist"},{"key":"1352_CR55","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1016\/j.jhin.2008.02.001","volume":"68","author":"D Yang","year":"2008","unstructured":"Yang D, Zhang Z (2008) Biofilm-forming Klebsiella pneumoniae strains have greater likelihood of producing extended-spectrum \u03b2-lactamases. J Hosp Infect 68:369\u2013371","journal-title":"J Hosp Infect"},{"key":"1352_CR56","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2024.107068","volume":"197","author":"R Zhang","year":"2024","unstructured":"Zhang R, Liu Y, Wang S et al (2024) Anti-bacteria, anti-biofilm, and anti-virulence activity of the synthetic compound MTEBT-3 against carbapenem-resistant Klebsiella pneumoniae strains ST3984. Microb Pathog 197:107068","journal-title":"Microb Pathog"}],"container-title":["Folia Microbiologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01352-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12223-025-01352-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12223-025-01352-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T07:03:02Z","timestamp":1760684582000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12223-025-01352-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,17]]},"references-count":55,"alternative-id":["1352"],"URL":"https:\/\/doi.org\/10.1007\/s12223-025-01352-7","relation":{},"ISSN":["0015-5632","1874-9356"],"issn-type":[{"type":"print","value":"0015-5632"},{"type":"electronic","value":"1874-9356"}],"subject":[],"published":{"date-parts":[[2025,10,17]]},"assertion":[{"value":"8 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"The project was approved by the Kerman University of Medical Sciences, Kerman, Iran, Ethical Committee, with the Ethical approval Code IR.KMU.REC. IR.KMU. REC.1403.514. All methods or experiments were performed following relevant guidelines of the Declaration of Helsinki. Bacterial isolates were collected from teaching hospital laboratories as part of routine hospital procedure and written informed consent was obtained from all the patients enrolled in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical trial number"}}]}}